GOOD JENNIFER L
SEC insider (Form 3/4/5 filer). CIK 0001229245. Director at RHYTHM PHARMACEUTICALS, INC. (RYTM) and 1 other issuer. 31 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in BOSTON, MA.
Companies GOOD JENNIFER L has filed insider reports for
- RHYTHM PHARMACEUTICALS, INC. (RYTM): Director
- Trevi Therapeutics, Inc. (TRVI): Director, Officer, President & CEO
GOOD JENNIFER L
CIK: 0001229245
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (31 total)
- Jun 24, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
2.3K shares- - Jun 24, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectStock Option (right to buy)
3.7K shares- - Jun 23, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect4.7K shares- - Feb 19, 2026TRVI
Trevi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
675K shares- - Jun 24, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectStock Option (right to buy)
7K shares- - Jun 24, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
4.7K shares- - Jun 18, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect4K shares- - May 31, 2025TRVI
Trevi Therapeutics, Inc.
AwardDirectPerformance Stock Option (right to buy)
102K shares- - Mar 21, 2025TRVI
Trevi Therapeutics, Inc.
SaleDirect5.3K shares at avg. $6.58$35K - Mar 21, 2025TRVI
Trevi Therapeutics, Inc.
ExerciseDirect5.3K shares at avg. $1.43$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 |  RYTM RHYTHM PHARMACEUTICALS, INC. | Award Restricted Stock Units | 2,324 | - | - | Direct |
| Jun 24, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Stock Option (right to buy) | 3,691 | - | - | Direct |
| Jun 23, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 4,712 | - | $0 | Direct |
| Feb 19, 2026 |  TRVI Trevi Therapeutics, Inc. | Award Stock Option (right to buy) | 675,000 | - | - | Direct |
| Jun 24, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Stock Option (right to buy) | 7,037 | - | - | Direct |
| Jun 24, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Restricted Stock Units | 4,712 | - | - | Direct |
| Jun 18, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 4,000 | - | - | Direct |
| May 31, 2025 | TRVI Trevi Therapeutics, Inc. | Award Performance Stock Option (right to buy) | 102,000 | - | - | Direct |
| Mar 21, 2025 | TRVI Trevi Therapeutics, Inc. | Sale | 5,263 | $6.58 | $34,625 | Direct |
| Mar 21, 2025 | TRVI Trevi Therapeutics, Inc. | Exercise | 5,263 | $1.43 | $7,526 | Direct |
1-10 of 31 transactions